Resource Summary Report  New Search Previous Search Results

URL: https://dx.doi.org/DOI:10.17504/protocols.io.mwgc7bw

Authors: Jose Mendoza-Sanchez

Summary: Multicriteria desicion analysis (MCDA) is a tool used to perform quantitative benefit-risks assessment (BRA) anlysis in drugs, procedures and devices in health. It allows comparisons in the same indication, that allows quantitative BRA balances, is useful to shows results in a transparency and consistency manner and also to communicate easily to the stakeholders.MCDA has emerged as a promising tool in the decision context for drugs, although its use has been relegated to assess drugs in the context of medicine reimbursment and a few for benefits, risks and others assessments in medicines for a particular indication. One of the major advantages of MCDA is the inclusion of criterian weights that is "preferences". this roadmap to formulate a MCDA compile the recomendations of IMI-PROTECT and ISPOR task force to easy, explicit and transparent election of criteria included in a MCDA.

Associated Publications: Mendoza-Sanchez J, Silva F, Rangel L, Jaramillo L, Mendoza L, Garzon J, Quiroga A (2018) Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis. PLoS ONE 13(5): e0196361. doi: 10.1371/journal.pone.0196361

Affiliations: Hospital Internacional de Colombia, Cardiecol

External URL: https://doi.org/10.1371/journal.pone.0196361

Version: 1

Publication Date: 2018

Expand All Collapse